Patent · US Active

Compositions and methods for inhibiting cancer stem cells

US11192948B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2016
Grant dateDec 7, 2021
Priority date
Expiry dateSep 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2318/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express LOX1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.